Upload
delhi-south
View
0
Download
0
Embed Size (px)
Citation preview
Molecular characterizationof b-lactamasegenesblaA andblaBofYersinia enterocolitica biovar1ASachin Sharma, Shilpi Mittal, Sarita Mallik & Jugsharan S. Virdi
Microbial Pathogenicity Laboratory, Department of Microbiology, University of Delhi South Campus, New Delhi, India
Correspondence: Jugsharan S. Virdi,
Microbial Pathogenicity Laboratory,
Department of Microbiology, University of
Delhi South Campus, Benito Juarez Road,
New Delhi 110 021, India. Tel.: 191 11
24110950; fax: 191 11 24115270; e-mail:
Received 30 November 2005; revised 4 January
2006; accepted 6 February 2006.
First published online March 2006.
doi:10.1111/j.1574-6968.2006.00191.x
Editor: Marco Soria
Keywords
biovar 1A; b-lactamase genes; Yersinia
enterocolitica; RFLP; isoelectric focusing.
Abstract
The b-lactamase genes blaA and blaB were detected by PCR amplification in
strains of Yersinia enterocolitica biovar 1A isolated from India, Germany, France
and the USA. Both genes were detected in all strains. Polymerase chain reaction-
restriction fragment length polymorphism revealed genetic heterogeneity in blaA
but not in blaB. Cluster analysis of blaA restriction profiles grouped the strains into
three groups. The blaA gene of Y. enterocolitica biovar 1A showed a high degree of
sequence homology to that of Y. enterocolitica 8081 (biovar 1B) and Y. enterocoli-
tica Y-56 (biovar 4), whereas homology was low with class A b-lactamase genes
of other members of the family Enterobacteriaceae. The pI 8.7 of enzyme Bla-A
of Y. enterocolitica biovar 1A was similar to that of biovars 2, 3 and 4. The enzyme
Bla-B focused at 6.8 and 7.1, indicating that biovar 1A strains produced a ‘B-like’
enzyme. This is the first study to have investigated the genetic heterogeneity of
the b-lactamase genes of Y. enterocolitica.
Introduction
Yersinia enterocolitica, an important food- and water-borne
enteropathogen, is known to cause a variety of gastrointest-
inal problems including acute diarrhea, terminal ileitis
and mesenteric lymphadenitis. Long-term sequelae following
infection include reactive arthritis and erythema nodosum
(Bottone, 1999). Blood transfusion-associated septicemia
because of Y. enterocolitica has been reported
to have a high mortality rate (Leclercq et al., 2005).
Yersinia enterocolitica is highly heterogeneous and is repre-
sented by six biovars (1A, 1B, 2, 3, 4 and 5) and more than 50
serovars. These biovars differ in their geographical distribu-
tion, ecological niches and pathogenic properties (Bottone,
1999). Strains belonging to different biovar/serovar combi-
nations may exhibit different susceptibilities to b-lactams
(Pham & Bell, 1993a; Pham et al., 2000; Stock et al., 2000),
which may be due to the expression of two chromosomal b-
lactamases. Bla-A is a class A constitutive broad spectrum
penicillinase whereas Bla-B is a class C inducible cephalos-
porinase (AmpC) (Pham et al., 1991a, b). The distribution
and expression of the two lactamases in different biovars of Y.
enterocolitica has been well studied (Pham et al., 1999; Stock
et al., 1999, 2000; Sharma et al., 2004).
However, there have been few studies of bla genes of Y.
enterocolitica strains, except those isolated in Europe. Biovar
2, 3, 4 and 5 strains of European origin were shown to
possess both blaA and blaB genes (Stock et al., 1999, 2000).
Biovar 1A strains unequivocally showed the presence of the
blaB gene by PCR, but amplification of blaA gave multiple
faint bands. This was speculated to be due to the genetic
variability of the blaA gene (Stock et al., 2000). These
observations clearly warrant further studies of the bla genes
of Y. enterocolitica isolated in different parts of the world.
Moreover, knowledge about the genetic heterogeneity of bla
genes may be pivotal to understanding biovar-specific
expression of b-lactamases in Y. enterocolitica. The present
work reports molecular detection and heterogeneity in blaA
and blaB genes of Y. enterocolitica biovar 1A isolated from
India (Singh & Virdi, 1999; Sinha et al., 2000; Singh et al.,
2003), France, Germany and the USA.
Materials and methods
Bacterial strains
Eighty one strains of Yersinia enterocolitica biovar 1A were
examined. Among these, 65 strains were isolated from
FEMS Microbiol Lett 257 (2006) 319–327 c� 2006 Federation of European Microbiological SocietiesPublished by Blackwell Publishing Ltd. All rights reserved
clinical and nonclinical sources viz. diarrheic human sub-
jects (35 strains), wastewater (18 strains), pig throat (seven
strains) and pork (five strains) in India. All these isolates
have been authenticated by, and deposited with the Yersinia
National Reference Laboratory and WHO Collaborating
Center, Pasteur Institute, Paris (France). Of the remaining
16 isolates, 10 were kindly provided by Elisabeth Carniel
(Yersinia National Reference Laboratory and WHO Colla-
borating Center, Pasteur Institute, Paris, France) and six
were procured from J. Heesemann (Max von Pattenkofer
Institute, Munich, Germany). The serovars, source of isola-
tion, country of origin and reference laboratory accession
numbers of these strains have been reported previously
(Sachdeva & Virdi, 2004). All strains were maintained on
trypticase soy agar (HiMedia, Mumbai, India) at 4 1C.
DNA extraction
Genomic DNA was extracted from bacterial cultures grown
overnight at 28 1C in trypticase soy broth. One milliliter of
culture was pelleted by centrifugation (Sigma Loborzentri-
fugen GmbH, Osterode, Germany) at 7012 g for 10 min.
Total genomic DNA was prepared from each strain using the
DNeasy Tissue Kit (Qiagen, Hilden, Germany) with mod-
ifications for gram-negative bacteria according to the man-
ufacturer’s recommendations.
PCR amplification and sequencing of bla genes
PCR amplification of blaA and blaB genes was performed
with the primers (Microsynth GmbH, Balgach, Germany)
listed in Table 1, using a PTC-100TM (MJ Research, Wal-
tham, MA) thermal cycler. The PCR reaction mixture
comprised 1� PCR buffer (10 mM Tris-HCl, 1.5 mM
MgCl2, 1.5 mM KCl and 0.1% Triton X-100), 200 mM each
of the four dNTPs (MBI Fermentas GmbH, St Leon-Rot,
Germany), 10 pmol each of forward and reverse primers
(Microsynth GmbH), 2 U of Taq DNA polymerase (DyNA-
zymeTM, Finnzymes, OY Espoo, Finland) and 50–100 ng of
genomic DNA in a total volume of 25 mL. For blaA, PCR was
performed at 95 1C for 5 min followed by 25 consecutive
cycles of 30 s at 95 1C, 30 s at 56 1C, and 90 s at 72 1C and a
final extension for 10 min at 72 1C. PCR for blaB was
performed as described by Stock et al. (1999) using the
primers indicated in Table 1. The PCR products were
analyzed by electrophoresis in a 1% (weight in volume)
agarose gel (GelroseTM LE, Life Technologies, New Delhi,
India). The gels were stained with ethidium bromide
(0.5 mg mL�1) and visualized under UV transillumination.
The PCR amplified products of bla genes of Y. enteroco-
litica biovar 1A were purified using the QIA Quick Gel
Extraction Kit (Qiagen, Hilden, Germany) and sequenced
using the Big Dye Terminator Cycle Sequencing Ready
Reaction kit in an ABI PRISM 310 Genetic Analyzer
(Applied Biosystems, Frankfurt, Germany). The nucleotide
sequences were analyzed by BLASTN, available at the
National Center for Biotechnology Information website
(http://www.ncbi.nlm.nih.gov/BLAST). The nucleotide and
the deduced amino-acid sequences of the blaA gene of Y.
enterocolitica biovar 1A were aligned with class A b-lacta-
mases of Y. enterocolitica 8081 (biovar 1B), Y. enterocolitica
Y-56 (biovar 4) and other members of the family Enterobac-
teriaceae using ClustalW (http://www.ebi.ac.uk/clustalW).
Restriction fragment length polymorphism(RFLP) of bla genes
The PCR amplified products of blaA and blaB genes were
restricted with NciI and DraI, and with HaeIII and RsaI,
respectively. Twenty-five microliters of PCR product was
digested with 1 U of each enzyme separately by incubating at
37 1C for 12 h in the appropriate buffer as recommended by
the supplier (New England Biolabs, Schwalbach, Germany).
The digested DNA samples were resolved in a 2% agarose gel
in 1� Tris-acetate-EDTA (TAE) buffer at 60 V for 6 h. The
gels were stained with ethidium bromide and photographed
using the Gel Doc 2000 (Bio-Rad, Hercules, CA). Genetic
similarity was determined by cluster analysis of restriction
profiles of blaA using NTSYSpc 2.02i software package and
the dendrogram was constructed by the unweighted pair
group method using arithmetic averages (UPGMA).
Molecular weight determinations of enzymesBla-A and Bla-B
Preparation of cell lysates containing Bla-A (uninduced)
and Bla-B (induced with imipenem) was carried out by
sonication of the washed cell pellet in cold buffer and
Table 1. Details of primers used in this study
Primer Sequence (50–30) Gene Expected amplicon size (bp) Reference
blaA5 AAATGCGCTACCGGCTTCAG blaA 439 Stock et al. (1999)
blaA3 AGTGGTGGTATCACGTGGGT
A9-f GAGATTCAGGAATGAAGCACTCTTCG blaA 896 This study
A10-r TCAGGATATTTGCGACAAAATTAT
blaB5 CCCACTTTATACCTTGGCACAAA blaB 827 Stock et al. (1999)
blaB3 GAACATATCTCCTGCCTGGGAAAT
FEMS Microbiol Lett 257 (2006) 319–327c� 2006 Federation of European Microbiological SocietiesPublished by Blackwell Publishing Ltd. All rights reserved
320 S. Sharma et al.
sedimentation as described previously (Sharma et al., 2004).
Cell lysates containing the enzymes were subjected to
sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) as described by Laemmli (1970). After PAGE,
the gel was washed twice in renaturation buffer (100 mM
Tris-HCl, pH 7.0 and 0.1% Triton-X-100) under mild
shaking for 45 min each. b-lactamase activity was detected
by overlaying the polyacrylamide gel with Whatman filter
paper soaked in 0.5 mg mL�1 nitrocefin (Oxoid, Basing-
stoke, England) for 2 min.
Isoelectric focusing (IEF) of Bla-A and Bla-B
Isoelectric focusing of the cell extracts containing the crude
enzymes was performed in a 6% polyacrylamide gel contain-
ing 2% ampholyte of pH 3–10 (Biolyte Ampholyte, Bio-
Rad). The extract containing 3 mg of protein was applied to
the gel, and focused at 4 1C using a Mini IEF cell (Bio-Rad)
according to the protocol specified by the manufacturer.
Broad range IEF standard with pI ranging from 4.45 to 9.6
(Bio-Rad) was used as the pI marker. After focusing, the b-
lactamase bands were visualized by overlaying the gel with
nitrocefin as described above. Detection of Bla-A and Bla-B
on the IEF gel was further confirmed by the selective
inhibition of these enzymes by clavulanic acid (CLA) and
aztreonam (ATM), respectively. For this, the gel was overlaid
with filter paper soaked in 40mM CLA or 20 mM ATM for
2 min before the application of nitrocefin.
Nucleotide sequence accession numbers
The complete coding sequence of blaA and partial nucleo-
tide sequence of blaB have been submitted to GenBank-
EMBL database under accession numbers AY954728 and
DQ150252, respectively.
Results and discussion
Primer design and PCR amplification of blaA
When published primers blaA5 and blaA3 (Table 1) were
used to amplify the blaA gene of Yersinia enterocolitica
biovar 1A strains, amplicons of 1100 and 1200 bp were
obtained, instead of the 479 bp as reported for biovar 2, 4
and 5 strains (Stock et al., 1999). These amplicons were
obtained for all 81 strains of Y. enterocolitica biovar 1A
studied. A similar observation was made by Stock et al.
(2000), when they used these primers for amplification of
blaA gene of biovar 1A strains isolated in Germany. They
reported the appearance of multiple faint bands in the
region of 1500 bp (Stock et al., 2000).
Consequently, in order to amplify the blaA gene of Y.
enterocolitica biovar 1A strains, consensus primers A9-f and
A10-r (Table 1) were designed from the conserved regions of
the blaA genes of Y. enterocolitica 8081, biovar 1B (http://
www.sanger.ac.uk/Projects/Y_enterocolitica), Y. enterocoliti-
ca Y-56, biovar 4 (Seoane & Garcia-Lobo, 1991a), and
Klebsiella oxytoca (Arakawa et al., 1989). These primers
amplified a 896 bp fragment unequivocally from all the 81
strains of Y. enterocolitica biovar 1A. Sequencing of one such
amplicon confirmed it to be the complete coding sequence
of the blaA gene of Y. enterocolitica.
RFLP, cluster analysis and sequence comparisonof blaA
Heterogeneity in blaA gene of Y. enterocolitica biovar 1A was
studied by RFLP of the amplified 896 bp CDS, using NciI
and DraI. Restriction digestion of blaA with NciI gave three
different restriction profiles having 800 and 100 bp, 650 and
250 bp, and 550, 220 and 130 bp fragments, indicating
limited heterogeneity (Fig. 1a). Digestion with DraI did not
show any polymorphism in blaA gene and resulted in the
consistent appearance of two fragments of sizes 550 and
350 bp. The profile obtained with NciI suggested that poly-
morphism observed in the blaA gene was due to the presence
of four recognition sites for NciI. The heterogeneity in the
blaA gene of Y. enterocolitica biovar 1A strains was also
reflected in an earlier study, in which differential expression
of enzyme Bla-A was reported by the double disc diffusion
synergy test (Sharma et al., 2004). The genetic background
of the antibiotic resistance genes has been shown to influ-
ence the minimal inhibitory concentrations of streptomycin
in Escherichia coli (Sunde & Norstrom, 2005) and of
penicillin in Streptococcus pneumoniae (Beall et al., 1998).
A similarity analysis of restriction profiles of the blaA
gene obtained with NciI, clustered the isolates into three
M 1 2 3 4 5 6 M 7 8 9 10 11 121000 bp
600 bp
200 bp
100 bp
(a) (b)
Fig. 1. (a) Restriction profile of blaA with en-
donucleases NciI (Lanes 1–3) and DraI (Lanes
4–6). (b) Restriction profile of blaB with endo-
nucleases RsaI (Lanes 7–9) and HaeIII (Lanes
10–12). PCR amplification and restriction analy-
sis were carried out for 81 strains of Yersinia
enterocolitica biovar 1A. M, 100 bp DNA ladder.
FEMS Microbiol Lett 257 (2006) 319–327 c� 2006 Federation of European Microbiological SocietiesPublished by Blackwell Publishing Ltd. All rights reserved
321Molecular characterization of b-lactamase genes blaA and blaB
major groups – A, B and C (Fig. 2). Group A comprised
primarily the clinical isolates, whereas there was preponder-
ance of nonclinical isolates in the group B. The groups were
related to each other at 49.5% similarity. Group C was
represented by both clinical and nonclinical isolates in
almost equal numbers. This group was related to the other
two at approximately 23% similarity. All except one ser-
ogroup O:6,30-6,31 isolates of clinical origin clustered into
group A, whereas those of non-clinical origin clustered into
group B. The clinical serogroup O:6,30-6,31 isolates of
StrainID
Serovar Source Countryof origin
0.23 0.42 0.61 0.81 1.00Coefficient
(a)
(b)
(c)
Fig. 2. Phylogenetic analysis of blaA gene of Yersinia enterocolitica biovar 1A based on restriction profiling. ND, not determined; NK, not known; NAG,
nonagglutinable. (For more details of the strains refer to Sachdeva & Virdi, 2004.)
FEMS Microbiol Lett 257 (2006) 319–327c� 2006 Federation of European Microbiological SocietiesPublished by Blackwell Publishing Ltd. All rights reserved
322 S. Sharma et al.
Indian, European and American origin showed identical
profiles. Previously, the BRO b-lactamases BRO-1 and BRO-
2 of Moraxella catarrhalis, which differ from each other in
just five bases, have also been differentiated by restriction
fragment length polymorphism (Plessis, 2001; Koseoglu
et al., 2004). The blaCTX-M genes of K. pneumoniae were also
differentiated using PCR-RFLP (Edelstein et al., 2003).
The grouping of the strains of Y. enterocolitica biovar 1A
based on restriction profiling of blaA is in agreement with an
earlier study from our laboratory in which clustering of the
same collection of Y. enterocolitica biovar 1A strains was
performed using repetitive extragenic palindrome (REP)-
and enterobacterial repetitive intergenic consensus (ERIC)-
PCR based fingerprinting (Sachdeva & Virdi, 2004). A
correlation between REP/ERIC types (Sachdeva & Virdi,
2004) and restriction profile of blaA was also discerned. For
example, REP type 1 (R1) was predominantly associated
with blaA group A, whereas ERIC type 4 (E4) was exclusively
associated with blaA group C. Also, as with rep (REP/ERIC)-
PCR fingerprinting (Sachdeva & Virdi, 2004), the clinical
and wastewater serogroup O:6,30-6,31 strains clustered into
two separate groups. Another study reported that restriction
profiles of b-lactamase genes (blaOXY-1, blaOXY-2) of K.
oxytoca correlated very well with ERIC-PCR profiles (Gran-
ier et al., 2003). These observations suggest that restriction
analysis of b-lactamase genes may be used to study epide-
miology, or discern phylogenetic relationships. It would be
of interest to explore further if restriction profiling of bla
genes, such as blaA, may provide epidemiological/phyloge-
netic information about Y. enterocolitica and ‘Y. enterocoliti-
ca-like’ species (Virdi & Sachdeva, 2005) as obtained from
other loci such as rrn (Kotetishvili et al., 2005) or gyrB
(Demarta et al., 2004).
Nucleotide sequence comparison of the blaA gene of Y.
enterocolitica biovar 1A with that of Y. enterocolitica Y-56
(biovar 4) and Y. enterocolitica 8081 (biovar 1B) revealed
a high degree of identity (93%). However, the homology of
the blaA gene with that of chromosomal class A b-lactamase
genes of other members of the family Enterobacteriaceae viz.
K. oxytoca (Arakawa et al., 1989) and Citrobacter koseri
(Perilli et al., 1991) was c. 50%, which was relatively low
(Fig. 3). The low sequence similarities of blaA of
Fig. 3. Nucleotide sequence alignment of blaA genes. Dashes indicate gaps inserted in the alignment, and asterisks indicate identical nucleotides in
the five genes. GenBank accession numbers of the genes are as follows: AY954728 (Yersinia enterocolitica biovar 1A, present study), 8081_biovar 1B
(Y. enterocolitica 8081 biovar1B), X57074 (Y. enterocolitica Y-56 biovar 4), M27459 (Klebsiella oxytoca), X62610 (Citrobacter koseri).
FEMS Microbiol Lett 257 (2006) 319–327 c� 2006 Federation of European Microbiological SocietiesPublished by Blackwell Publishing Ltd. All rights reserved
323Molecular characterization of b-lactamase genes blaA and blaB
Y. enterocolitica biovar 1A with class A b-lactamase genes of
K. oxytoca and C. koseri suggested separate lineages of these
genes. The percent amino-acid sequence identity was high
with Y. enterocolitica Y-56, biovar 4 and Y. enterocolitica
8081, biovar 1B (93–94%) compared with those of K.
oxytoca (55.7%) and C. koseri (53.4%). The amino-acid
sequence alignment of chromosomal class A b-lactamases is
shown in Fig. 4. Multiple sequence alignment showed the
presence of four highly conserved motifs viz., a serine-
threonine-phenylalanine-lysine (STFK) at position 70–74,
serine-aspartic acid-asparagine (SDN) at position 130–132,
glutamate-X-X-leucine-asparagine (EXXLN) at position
166–170 and KTG at position 234–236. STFK, SDN and
KTG are characteristic of class A b-lactamases possessing a
serine active site and are known to be involved in catalytic
mechanism and substrate binding. Another motif, EXXLN, is
characteristic of O loop formation (Cheung et al., 2002). The
presence of an O loop in Bla-A of Y. enterocolitica biovar 1A
suggests that the enzyme has a globular shape (Fetrow, 1995).
PCR amplification, RFLP and sequencecomparison of blaB
The primers blaB5 and blaB3, described by Stock et al.
(1999), consistently amplified the 871 bp fragment of the
blaB for all the isolates of Y. enterocolitica biovar 1A. RFLP
AAX55643 MKHSSLRRALLLAGITLPLVNFSLPTWAAAI--PGSLDKQLAALEHSANGRLGIAMINTG8081_biovar1B MKHSSLRRSLLLAGITLPLVNFALPTWAAAI--PGSLDKQLAALEHSANGRLGIAMINSGCAA40357 MKHSSLRRSLLLAGITLPLVSFALPAWANAL--PASVDKQLAELERNANGRLGVAMINTGAAA25084 MLKSSWRKTALMAAAAVPLLLASGSLWASAD----AIQQKLADLEKRSGGRLGVALINTACAA44485 MFKKRGRQTVLIAAVLA-FFTASSPLLARTQGEPTQVQQKLAALEKQSGGRLGVALINTA * :. *:: *:*. .:. : . * : . ::::** **: :.****:*:**:.
AAX55643 NGTKILYRGARRFPFCSTFKFMLAAAVLGQSQSQPNLLNKHINYHESDLLSYAPITRKNL8081_biovar1B AGTKILYRGAQRFPFCSTFKFMLAAAVLDQSQSQPNLLNKHINYHESDLLSYAPITRKNLCAA40357 NGTKILYRAAQRFPFCSTFKFMLAAAVLDQSQSQPNLLNKHINYHESDLLSYAPITRKNLAAA25084 DDSQTLYRGDERFAMCSTGKVMAAAAVLKQSESNPEVVNKRLEIKKSDLVVWSPITEKHLCAA44485 DRSQILYRGDERFAMCSTSKTMVAAAVLKQSETQHDILQQKMVIKKADLTNWNPVTEKYV :: ***. .**.:*** * * ***** **::: ::::::: :::** : *:*.* :
AAX55643 AHGMTVSELCAATIQYSDNTAANLLLKELGGLAAVNQFARSIGDQMFRLDRWEPDLNTAL8081_biovar1B ACGMTVSELCAATIQYSDNTAANLLIKELGGLAAVNQFARSIGDQMFRLDRWEPDLNTALCAA40357 AHGMTVSELCAATIQYSDNTAANLLIKELGGLAAVNQFARSIGDQMFRLDRWEPDLNTARAAA25084 QSGMTLAELSAAALQYSDNTAMNKMISYLGGPEKVTAFAQSIGDVTFRLDRTEPALNSAICAA44485 DKEMTLAELSAATLQYSDNTAMNKLLEHLGGTSNVTAFARSIGDTTFRLDRKEPELNTAI **::**.**::******* * ::. *** *. **:**** ***** ** **:*
AAX55643 PNDPRDTTTPAAMAASINKLVLGDALHPAQRSQLTAWLKGNTTGDATIRAGAPTDWIVGD8081_biovar1B PNDPRDTTTPAAMAASMNKLVLGDALRPAQRSQLAAWLKGNTTGDATIRAGAPTDWIVGDCAA40357 PNDPRDTTTPAAMAASMNKLVLGDALRPAQRSQLAVWLKGNTTGDATIRAGAPTDWIVGDAAA25084 PGDKRDTTTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPASWAVGDCAA44485 PGDERDTTCPLAMAKSLHKLTLGDALAGAQRAQLVEWLKGNTTGGQSIRAGLPEGWVVGD *.* **** * *** *:.**.**:** **:**. ********. :**** * .* ***
AAX55643 KTGSGDYGTTNDIAVLWPTKGAPIVLVVYFTQREKDAKPRRDVLASATKIILS---8081_biovar1B KTGSGDYGTTNDIAVLWPTKGAPIVLVVYFTQREKDAKPRRDVLASATQIILSQISCAA40357 KTGSGDYGTTNDIAVLWPTKGAPIVLVVYFTQREKDAKPRRDVLASVTKIILS---AAA25084 KTGAGDYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKSRKEVLAAAAKIVTEGL-CAA44485 KTGAGDYGTTNDIAVIWPEDRAPLILVTYFTQPQQDAKGRKDILAAAAKIVTEGL- ***:***********:** . **::**.**** ::*** *:::**:.::*: .
234
130 166
70
Fig. 4. Amino-acid sequence alignment of b-lactamase (Bla-A) from Yersinia enterocolitica biovar 1A (strain ID 1) with its nearest b-lactamase class A
neighbors. Asterisks indicate identical amino acids. The conserved motifs (70SXXK73, 130SDN132 and 234KTG236) typical of class A b-lactamases are in
boldface. The motif 166EXXLN170 responsible for O loop formation is in boldface and italics. Arrows indicate the putative O loop region. GenBank
accession numbers of the b-lactamases are as follows: AAX55643 (present study), CAA40357 (Y-56), AAA25084 (Klebsiella oxytoca) CAA44485
(Citrobacter koseri).
FEMS Microbiol Lett 257 (2006) 319–327c� 2006 Federation of European Microbiological SocietiesPublished by Blackwell Publishing Ltd. All rights reserved
324 S. Sharma et al.
with two endonucleases viz. RsaI and HaeIII resulted in the
consistent appearance of two fragments of 550 and 324 bp
for RsaI, and 650 and 110 bp for HaeIII in all the strains,
suggesting that there was no polymorphism in this gene
(Fig. 1b). The lack of heterogeneity in this gene was also
suggested by the fact that the blaB gene of Y. enterocolitica
biovar 1A strains could be amplified unequivocally with
primers designed for amplification of blaB of biovars 2, 3
and 5 (Stock et al., 1999). A previous investigation of Y.
enterocolitica biovar 1A strains also suggested a lack of
heterogeneity in Bla-B as identical expression of the enzyme
was seen in all the strains by the double disc-diffusion test
(Sharma et al., 2004).
Sequence analysis of the blaB gene of Y. enterocolitica
biovar 1A strain showed 96% nucleotide sequence identity
with that of Y. enterocolitica 8081, biovar 1B and Y. enter-
ocolitica IP97, biovar 2 (Seoane et al., 1992), and 88% with
Y. bercovieri ATCC 43970 ampC gene (Schiefer et al., 2005),
whereas sequence homology with other members of the
genus Yersinia (Y. aldovae and Y. ruckeri) was relatively low
(56–61%) (Schiefer et al., 2005).
Molecular weight determination and IEFanalysis of Bla-A and Bla-B
Two distinct bands having molecular weights of c. �35 and
�29 kDa were obtained on SDS-PAGE representing the
enzyme activities of Bla-A and Bla-B, respectively. A mole-
cular weight of �30 kDa has, however, been reported for
class A b-lactamases of Klebsiella oxytoca (Arakawa et al.,
1989), Burkholderia pseudomallei (Cheung et al., 2002),
Y. frederiksenii (Schiefer et al., 2005) and Citrobacter sedlakii
(Petrella et al., 2001). Bla-B, the inducible cephalos-
porinase (AmpC), was consistently found to be of 29 kDa.
This was further confirmed as induction by imipenem lead
to an increase in intensity of the band. This is in agreement
with previous reports that showed AmpC b-lactamases
have molecular weights in the range 29–39 kDa (Seoane
& Garcia-Lobo, 1991b; Weng et al., 2004; Schiefer et al.,
2005).
The two b-lactamases, Bla-A and Bla-B produced by Y.
enterocolitica have been distinguished by their distinct iso-
electric points (Pham et al., 1991a, 1995a, 1999, 2000; Pham
& Bell, 1993b). Table 2 shows IEF data of 81 strains of Y.
enterocolitica biovar 1A, for uninduced (Bla-A) and induced
(Bla-B) enzymes separately. Bla-A was visualized as a single
faint band in the alkaline region of the gel in all isolates and
exhibited a pI of 8.7. The intensity of the Bla-A band was
similar in both uninduced and induced enzyme prepara-
tions. The pI 8.7 for the enzyme Bla-A produced by
Y. enterocolitica biovar 1A strains was similar to that
produced by strains of biovars 2, 3 and 4 (Pham & Bell,
1993b; Pham et al., 1995b, 2000), or biovar 1A strains
isolated in other parts of the world (Pham & Bell, 1993b;
Pham et al., 2000).
Bla-B, on the other hand, was observed as multiple bands
on the IEF gel. Major bands were seen at pIs 6.8 and 7.1 for
all the isolates. This was in contrast to the reported pIs 5.3
and 5.7 of enzyme B, of other biovars (Pham et al., 1995a).
These results suggested that Y. enterocolitica biovar 1A
produces a ‘B-like’ enzyme instead of Bla-B. That the two
bands represented the enzyme ‘B-like’ was confirmed by
thickening and increase in the intensity of these bands
following induction with imipenem (Pham et al., 1991a).
Interestingly, although the majority of the Indian strains and
the sole American strain studied showed both bands, the
majority of the European strains showed either of the two
and rarely both. This may be attributed to differential
expression of enzymes in strains isolated in different parts
of the world as suggested by Pham et al. (2000). Minor
bands with pI 6.0 or 7.8 were also seen in a small percentage
of the strains. This however indicated the range of pI of ‘B-
like’ enzyme that may be elaborated by biovar 1A strains. In
the majority of the isolates, Bla-B was seen to express even
without induction. The isolates which did not show such
basal level of Bla-B activity, nevertheless expressed it after
induction with imipenem. Of the 35 clinical strains isolated
in India, two however failed to express the enzyme B even
after induction. The clinical and the nonclinical biovar 1A
strains did not show any difference in respect of the iso-
electric points of their enzymes.
Table 2. Isoelectric points (pI) of b-lactamases (Bla-A and Bla-B) of Yersinia enterocolitica biovar 1A
Strains n
pI
Bla-A Bla-B
Clinical
Indian 35 8.7 Both 6.8 and 7.1
European 15 8.7 Either 6.8 or 7.1; rarely both
American 1 8.7 Both 6.8 and 7.1
Nonclinical� 30 8.7 Both 6.8 and 7.1
�Isolated from India; includes wastewater (18 strains), pig throat (seven strains) and pork (five strains).
n, number of the strains studied.
FEMS Microbiol Lett 257 (2006) 319–327 c� 2006 Federation of European Microbiological SocietiesPublished by Blackwell Publishing Ltd. All rights reserved
325Molecular characterization of b-lactamase genes blaA and blaB
In conclusion, both blaA and blaB genes were detected in
biovar 1A strains of Y. enterocolitica by PCR amplification.
PCR-RFLP revealed heterogeneity in blaA, which was repre-
sented by three restriction profiles. The blaB failed to reveal
any such genetic heterogeneity. The cluster analysis of the
restriction profiles of blaA provided information broadly
similar to that inferred previously from rep (REP/ERIC)-
PCR fingerprinting of the isolates. To the best of our knowl-
edge, this is the first study in which the heterogeneity of the
chromosomal b-lactamase genes of Y. enterocolitica has been
investigated.
Acknowledgements
This work was supported by a grant to J. S. V. from Defense
Research and Development Organization, Govt. of India,
Senior Research Fellowship to S. S. from Indian Council of
Medical Research and postdoctoral fellowship to S. M. from
Department of Biotechnology. We thank Dr P. K. Burma for
help in primer design.
Sachin Sharma and Shilpi Mittal contributed equally to
this work.
References
Arakawa Y, Ohta M, Kido N, Mori M, Ito H, Komatsu T, Fujii Y &
Kato N (1989) Chromosomal b-lactamase of Klebsiella
oxytoca, a new class A enzyme that hydrolyzes broad-spectrum
b-lactam antibiotics. Antimicrob Agents Chemother 33: 63–70.
Beall B, Facklam RR, Jackson DM & Starling HH (1998) Rapid
screening for penicillin susceptibility of systemic
pneumococcal isolates by restriction enzyme profiling of the
pbp2B gene. J Clin Microbiol 36: 2359–2362.
Bottone EJ (1999) Yersinia enterocolitica: overview and
epidemiologic correlates. Microb Infect 1: 323–333.
Cheung TKM, Ho PL, Woo PCY, Yuen KY & Chau PY (2002)
Cloning and expression of class A b-lactamase gene blaABPS in
Burkholderia pseudomallei. Antimicrob Agents Chemother 46:
1132–1135.
Demarta A, De Respinis S, Dolina M & Peduzzi R (2004)
Molecular typing of Yersinia frederiksenii strains by means of
16S rDNA and gyrB genes sequence analyses. FEMS Microbiol
Lett 238: 423–428.
Edelstein M, Pimkin M, Palagin I, Edelstein I & Stratchounski L
(2003) Prevalence and molecular epidemiology of CTX-M
extended-spectrum beta-lactamase-producing Escherichia coli
and Klebsiella pneumoniae in Russian hospitals. Antimicrob
Agents Chemother 47: 3724–3732.
Fetrow JS (1995) Omega loops: nonregular secondary structures
significant in protein function and stability. FASEB J 9:
708–717.
Granier SA, Plaisance L, Leflon-Guibout V, Lagier E, Morand S,
Goldstein FW & Nicholas-Chanoine MH (2003) Recognition
of two genetic groups in the Klebsiella oxytoca taxon on the
basis of chromosomal b-lactamase and housekeeping gene
sequences as well as ERIC-1R PCR typing. Int J Syst Evol
Microbiol 53: 661–668.
Koseoglu O, Ergin A & Hascelik G (2004) Evaluation of
restriction endonuclease analysis of BRO beta-lactamases in
clinical and carrier isolates of Moraxella catarrhalis. Scand J
Infect Dis 36: 431–434.
Kotetishvili M, Kreger A, Wauters G Jr, Morris JG Jr, Sulakvelidze
A & Stine OC (2005) Multilocus sequence typing for studying
genetic relationships among Yersinia species. J Clin Microbiol
43: 2674–2684.
Laemmli UK (1970) Cleavage of structural proteins during the
assembly of the head of bacteriophage T4. Nature 227:
680–685.
Leclercq A, Martin L, Vergnes ML, Ounnoughene N, Laran JF,
Giraud P & Carniel E (2005) Fatal Yersinia enterocolitica
biotype 4 serovar O:3 sepsis after red blood cell transfusion.
Transfusion 45: 814–818.
Perilli M, Franceschini N, Segatore B, Amicosante G, Oratore A,
Duez C, Joris B & Frere JM (1991) Cloning and nucleotide
sequencing of the gene encoding the beta-lactamase from
Citrobacter diversus. FEMS Microbiol Lett 67: 79–84.
Petrella S, Clermont D, Casin I, Jarlier V & Sougakoff W (2001)
Novel class A b-lactamase Sed-1 from Citrobacter sedlakii:
genetic diversity of b-lactamases within the Citrobacter genus.
Antimicrob Agents Chemother 45: 2287–2298.
Pham JN & Bell SM (1993a) The detection by a disc diffusion
technique of inducible b-lactamase in Yersinia enterocolitica.
J Antimicrob Chemother 31: 1004–1005.
Pham JN & Bell SM (1993b) The prevalence of inducible b-
lactamase in clinical isolates of Yersinia enterocolitica.
Pathology 25: 385–387.
Pham JN, Bell SM & Lanzarone JYM (1991a) A study of the b-
lactamases of 100 clinical isolates of Yersinia enterocolitica.
J Antimicrob Chemother 28: 19–24.
Pham JN, Bell SM & Lanzarone JYM (1991b) Biotype and
antibiotic sensitivity of 100 clinical isolates of Yersinia
enterocolitica. J Antimicrob Chemother 28: 13–18.
Pham JN, Bell SM, Hardy MJ, Martin L, Guiyoule A & Carniel E
(1995a) Susceptibility to b-lactam agents of Yersinia
enterocolitica biotype 4, serotype O3 isolated in various parts
of the world. J Med Microbiol 43: 9–13.
Pham JN, Bell SM, Hardy MJ, Martin L, Guiyoule A & Carniel E
(1995b) Comparison of beta-lactamase production by Yersinia
enterocolitica biotype 4, serotype O:3 isolated in eleven
countries. Contrib Microbiol Immunol 13: 180–183.
Pham JN, Bell SM, Martin L & Carniel E (1999) The detection of
enzyme A of Yersinia enterocolitica by a disc diffusion method.
Pathology 31: 268–270.
Pham JN, Bell SM, Martin L & Carniel E (2000) The b-lactamases
and b-lactam antibiotic susceptibility of Yersinia enterocolitica.
J Antimicrob Chemother 46: 951–957.
Plessis MD (2001) Rapid discrimination between BRO b-
lactamases from clinical isolates of Moraxella catarrhalis using
FEMS Microbiol Lett 257 (2006) 319–327c� 2006 Federation of European Microbiological SocietiesPublished by Blackwell Publishing Ltd. All rights reserved
326 S. Sharma et al.
restriction endonuclease analysis. Diagn Microbiol Infect Dis
39: 65–67.
Sachdeva P & Virdi JS (2004) Repetitive elements sequence (REP/
ERIC)-PCR based genotyping of clinical and environmental
strains of Yersinia enterocolitica biotype 1A reveal existence of
limited number of clonal groups. FEMS Microbiol Lett 240:
193–201.
Schiefer AM, Wiegand I, Sherwood KJ, Wiedemann B & Stock I
(2005) Biochemical and genetic characterization of the
b-lactamases of Y. aldovae, Y. bercovieri, Y. frederiksenii
and ‘Y. ruckeri’ strains. Int J Antimicrob Agents 25:
496–500.
Seoane A & Garcia-Lobo JM (1991a) Nucleotide sequence of a
new class A b-lactamase gene from the chromosome of Yersinia
enterocolitica: implications for the evolution of class A
b-lactamases. Mol Gen Genet 228: 215–220.
Seoane A & Garcia-Lobo JM (1991b) Cloning of chromosomal b-
lactamase genes from Yersinia enterocolitica. J Gen Microbiol
137: 141–146.
Seoane A, Francia MV & Garcia-Lobo JM (1992) Nucleotide
sequence of the ampC–ampR region from the chromosome of
Yersinia enterocolitica. Antimicrob Agents Chemother 36:
1049–1052.
Sharma S, Ramnani P & Virdi JS (2004) Detection and assay
of b-lactamases in clinical and non-clinical strains of
Yersinia enterocolitica biovar 1A. J Antimicrob Chemother 54:
401–405.
Singh I & Virdi JS (1999) Isolation, biochemical characterization
and in vitro tests of pathogenicity of Yersinia enterocolitica
isolated from pork. Curr Sci 77: 1019–1021.
Singh I, Bhatnagar S & Virdi JS (2003) Isolation and
characterization of Yersinia enterocolitica from diarrhoeic
human subjects and other sources. Curr Sci 84: 1353–1355.
Sinha I, Choudhary I & Virdi JS (2000) Isolation of Yersinia
enterocolitica and Yersinia intermedia from wastewaters and
their biochemical and serological characteristics. Curr Sci 79:
510–513.
Stock I, Heisig P & Wiedemann B (1999) Expression of b-
lactamases in Yersinia enterocolitica strains of biovars 2, 4 and
5. J Med Microbiol 48: 1023–1027.
Stock I, Heisig P & Wiedemann B (2000) b-lactamase expression
in Yersinia enterocolitica biovars 1A, 1B and 3. J Med Microbiol
49: 403–408.
Sunde M & Norstrom M (2005) The genetic background for
streptomycin resistance in Escherichia coli influences the
distribution of MICs. J Antimicrob Chemother 56: 87–90.
Virdi JS & Sachdeva P (2005) Molecular heterogeneity in Yersinia
enterocolitica and ‘Y. enterocolitica-like’ species � implications
for epidemiology, typing and taxonomy. FEMS Immunol Med
Microbiol 45: 1–10.
Weng SF, Chao YF & Lin JW (2004) Identification and
characteristic analysis of the ampC gene encoding b-lactamase
from Vibrio fischeri. Biochem Biophys Res Commun 314:
838–843.
FEMS Microbiol Lett 257 (2006) 319–327 c� 2006 Federation of European Microbiological SocietiesPublished by Blackwell Publishing Ltd. All rights reserved
327Molecular characterization of b-lactamase genes blaA and blaB